Search
for
Sort by
Research 571–600 of 1000+
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Post‐finasteride syndrome: real or myth?
- Identification of a Rare Variant in the <i>SRD5A2</i> Gene in Siblings With 46,XY Disorders of Sexual Development
- Identification of a Cyclosporine-Specific P450 Hydroxylase Gene through Targeted Cytochrome P450 Complement (CYPome) Disruption in Sebekia benihana
- Anti-androgenic activities of Ganoderma lucidum
- Guideline for the primary care management of male lower urinary tract symptoms
- Androgenetic alopecia; drug safety and therapeutic strategies
- 黃柏이 前立腺肥大症 Rat에 미치는 영향
- A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Post-finasteride syndrome: An emerging clinical problem
- Kyoh® Rocket Leaf Extract Regulates Proliferation and VEGF and FGF7 Expression in Human Dermal Follicle Papilla Cells
- Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
- Caída capilar: nuevos factores causales y nuevos principios activos para un abordaje más integral con complementos alimenticios
- Phytochemistry and pharmacological studies of Plumbago zeylanica L.: a medicinal plant review
- Alternative Medicine for Hair Loss
- Reply by Authors
- Androgenetik Alopesi
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Managing patterned hair loss – a hair raising task!
- Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development
- Role and Mechanisms of Phytochemicals in Hair Growth and Health
- Screening the Chemical Composition and Bioactivity of <i>Cerasus serrulata</i> Flower Extracts Using Two Extraction Methods
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Clinical use of 5α-reductase inhibitors
- Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome